David Johnson
2021 - Enveric Biosciences
In 2021, David Johnson earned a total compensation of $6.9M as Executive Chairman at Enveric Biosciences, a 3,344% increase compared to previous year.
Compensation breakdown
| Bonus | $168,750 |
|---|---|
| Salary | $250,000 |
| Stock Awards | $6,469,066 |
| Total | $6,887,816 |
Johnson received $6.5M in stock awards, accounting for 94% of the total pay in 2021.
Johnson also received $168.8K in bonus and $250K in salary.
Rankings
In 2021, David Johnson's compensation ranked 1,790th out of 12,415 executives tracked by ExecPay. In other words, Johnson earned more than 85.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,790 out of 12,415 | 86th |
Division Manufacturing | 665 out of 5,505 | 88th |
Major group Chemicals And Allied Products | 249 out of 2,375 | 90th |
Industry group Drugs | 210 out of 2,096 | 90th |
Industry Pharmaceutical Preparations | 144 out of 1,546 | 91st |
Source: SEC filing on September 23, 2022.
Johnson's colleagues
We found four more compensation records of executives who worked with David Johnson at Enveric Biosciences in 2021.